Hypertension

Reading File

Finding Sources

Hypertension is a broad topic covered across multiple textbooks (Family Medicine, Nephrology, Emergency Medicine sources). Here's a map of what it covers, followed by a brief overview.

Topic breakdown:

Definition, classification & epidemiology (BP thresholds, stages, prevalence)
Etiology - primary (essential) vs secondary hypertension (renal, endocrine, vascular causes)
Pathophysiology (RAAS, sympathetic activation, vascular remodeling, sodium handling)
Clinical evaluation & diagnostic workup (history, exam, labs, target-organ damage screening)
Complications (hypertensive heart disease, stroke, CKD, retinopathy, hypertensive emergencies/urgencies)
Management - lifestyle modification
Management - pharmacologic treatment (drug classes, first-line choices, compelling indications)
Special populations (pregnancy/preeclampsia, elderly, diabetic, CKD patients, resistant hypertension)
Hypertensive crisis (emergency vs urgency, management)

Brief overview:

Hypertension is sustained elevation of arterial blood pressure, generally defined as systolic BP ≥130 mmHg and/or diastolic BP ≥80 mmHg (per ACC/AHA) or ≥140/90 mmHg (per some other guidelines like ESC/WHO) - thresholds vary by guideline body. About 90-95% of cases are "primary" (essential) hypertension with no single identifiable cause, driven by a combination of genetic predisposition, sodium retention, sympathetic nervous system overactivity, and renin-angiotensin-aldosterone system (RAAS) dysregulation. The remaining 5-10% are "secondary," caused by identifiable conditions such as renal artery stenosis, primary aldosteronism, pheochromocytoma, Cushing syndrome, or obstructive sleep apnea.

Untreated hypertension is a major driver of cardiovascular disease, stroke, chronic kidney disease, and heart failure because of its damaging effects on vascular endothelium and end organs over time. Management centers on lifestyle changes (weight loss, sodium restriction, exercise, reduced alcohol) plus antihypertensive drug classes - ACE inhibitors/ARBs, thiazide diuretics, calcium channel blockers, and beta-blockers - chosen based on comorbidities and compelling indications (e.g., ACE inhibitors in diabetic nephropathy, beta-blockers post-MI).

Which topic would you like to go into in depth?

Asking for Preferences

Which aspect of hypertension do you want to explore in depth?

Hypertension is a broad topic covered across multiple textbooks (Family Medicine, Nephrology, Emergency Medicine sources). Here's a map of what it covers, followed by a brief overview.

Topic breakdown:

Definition, classification & epidemiology (BP thresholds, stages, prevalence)
Etiology - primary (essential) vs secondary hypertension (renal, endocrine, vascular causes)
Pathophysiology (RAAS, sympathetic activation, vascular remodeling, sodium handling)
Clinical evaluation & diagnostic workup (history, exam, labs, target-organ damage screening)
Complications (hypertensive heart disease, stroke, CKD, retinopathy, hypertensive emergencies/urgencies)
Management - lifestyle modification
Management - pharmacologic treatment (drug classes, first-line choices, compelling indications)
Special populations (pregnancy/preeclampsia, elderly, diabetic, CKD patients, resistant hypertension)
Hypertensive crisis (emergency vs urgency, management)

Brief overview:

Hypertension is sustained elevation of arterial blood pressure, generally defined as systolic BP ≥130 mmHg and/or diastolic BP ≥80 mmHg (per ACC/AHA) or ≥140/90 mmHg (per some other guidelines like ESC/WHO) - thresholds vary by guideline body. About 90-95% of cases are "primary" (essential) hypertension with no single identifiable cause, driven by a combination of genetic predisposition, sodium retention, sympathetic nervous system overactivity, and renin-angiotensin-aldosterone system (RAAS) dysregulation. The remaining 5-10% are "secondary," caused by identifiable conditions such as renal artery stenosis, primary aldosteronism, pheochromocytoma, Cushing syndrome, or obstructive sleep apnea.

Untreated hypertension is a major driver of cardiovascular disease, stroke, chronic kidney disease, and heart failure because of its damaging effects on vascular endothelium and end organs over time. Management centers on lifestyle changes (weight loss, sodium restriction, exercise, reduced alcohol) plus antihypertensive drug classes - ACE inhibitors/ARBs, thiazide diuretics, calcium channel blockers, and beta-blockers - chosen based on comorbidities and compelling indications (e.g., ACE inhibitors in diabetic nephropathy, beta-blockers post-MI).

Which topic would you like to go into in depth?It looks like my previous clarifying question didn't come through. Which aspect of hypertension would you like to explore in depth?

Diagnosis & classification
Causes (primary vs secondary)
Pathophysiology
Drug treatment/management
Complications
Hypertensive emergency/urgency
Special populations (pregnancy, CKD, elderly)

Let me know a number or topic and I'll go deep on it.

Explain pathophysiology of primary vs secondary hypertension

Finding Sources

Searching PubMed

"essential hypertension" AND pathophysiology

Reading File

Pathophysiology of Primary vs. Secondary Hypertension

Primary (Essential) Hypertension

Primary hypertension accounts for >90% of all hypertension cases and is defined by the absence of a single identifiable anatomic or biochemical lesion. Rather than one cause, it results from a convergence of genetic, renal, neural, hormonal, and vascular abnormalities that interact with environmental exposures.

Key mechanisms:

Genetic/polygenic susceptibility - Twin, family, and genome-wide association studies show BP heritability is real but driven by many genes of small individual effect (not single mutations), plus epigenetic modification. True monogenic hypertension syndromes exist but account for <1% of cases (Fuster and Hurst's The Heart, 15th ed.).
Renal sodium handling / pressure-natriuresis defect - A central unifying theory: the kidney's ability to excrete sodium at a given BP is impaired, so a higher perfusion pressure is needed to achieve natriuretic balance ("resetting" the pressure-natriuresis curve). This drives chronic volume/pressure elevation.
Renin-Angiotensin-Aldosterone System (RAAS) activation - Even without frank hyper-reninemia, tissue RAAS (especially in kidney, vasculature, heart) promotes vasoconstriction, sodium reabsorption (via aldosterone-driven ENaC upregulation), vascular smooth muscle proliferation, and fibrosis. Counter-regulatory ACE2/Angiotensin-(1-7)/Mas receptor pathways (vasodilatory, antiproliferative) are often relatively deficient (Brenner and Rector's The Kidney).
Sympathetic nervous system (SNS) overactivity - Consistently elevated sympathetic tone (confirmed via microneurography and catecholamine spillover studies) is seen from the earliest stages of hypertension, even in normotensive relatives of hypertensive patients. It is amplified by obesity, obstructive sleep apnea, and metabolic syndrome, and contributes to vasoconstriction and renal sodium retention (Brenner and Rector's The Kidney, Fig. 46.10). A 2025 meta-analysis in Hypertension (PMID: 40528744) reinforces that sympathetic overactivation is especially prominent in the resistant hypertension phenotype, supporting this mechanism.
Obesity/insulin resistance - Overweight and obesity alone account for an estimated 65-75% of primary hypertension risk, acting through SNS activation, leptin effects, and Angiotensin II-mediated renal sodium reabsorption.
Vascular remodeling and endothelial dysfunction - Chronic exposure to these pressor mechanisms causes structural changes in resistance vessels (medial hypertrophy, reduced lumen diameter) and reduced nitric oxide bioavailability, which further raises peripheral vascular resistance and perpetuates hypertension independent of the initial trigger.
Environmental/behavioral exposures - Excess dietary sodium, inadequate potassium intake, sedentary lifestyle, alcohol, and even chronic heavy-metal or air pollution exposure are all independently linked to higher BP (Harrison's Principles of Internal Medicine, 22nd ed.).

In short: primary hypertension is a multifactorial, self-reinforcing loop - no single lesion, but many contributing systems (renal, neural, hormonal, vascular) that push BP upward and adapt structurally over time, making it chronic and largely non-curable (managed rather than cured).

Secondary Hypertension

Secondary hypertension is elevated BP driven by a specific, identifiable, and often correctable/curable anatomic or biochemical abnormality. Each cause has its own distinct mechanism:

Cause	Core mechanism
Renovascular disease (renal artery stenosis)	Reduced renal perfusion pressure activates the juxtaglomerular apparatus, driving excess renin and Angiotensin II release. In unilateral stenosis with a normal contralateral kidney (two-kidney model), the stenotic kidney remains renin/Ang II-driven while the non-stenotic kidney retains sodium in response to the systemic pressure rise, sustaining hypertension through combined vasoconstrictive and volume mechanisms (Comprehensive Clinical Nephrology, 7th ed.).
Primary aldosteronism (Conn syndrome)	Autonomous aldosterone secretion from an adenoma or bilateral zona glomerulosa hyperplasia causes direct renal sodium retention, potassium wasting, and mineralocorticoid receptor-mediated vascular remodeling/fibrosis, independent of renin (Smith and Tanagho's General Urology, 19th ed.). It is the single most common cause of secondary hypertension.
Renal parenchymal disease (CKD)	Nephron loss reduces filtration surface area, triggering RAAS activation, sodium/water retention, and sympathetic overactivity - a self-perpetuating cycle that also accelerates further kidney injury.
Pheochromocytoma/paraganglioma	Catecholamine (epinephrine/norepinephrine)-secreting tumor causes direct alpha- and beta-adrenergic vasoconstriction and increased cardiac contractility/output, often with paroxysmal surges.
Cushing syndrome/glucocorticoid excess	Cortisol at high levels overwhelms 11-beta-hydroxysteroid dehydrogenase and activates mineralocorticoid receptors, mimicking aldosterone excess; also potentiates vascular sensitivity to catecholamines.
Obstructive sleep apnea	Intermittent nocturnal hypoxia triggers chemoreceptor-mediated sympathetic surges, oxidative stress, and endothelial dysfunction, raising both nocturnal and daytime BP.
Coarctation of the aorta	Mechanical obstruction proximal to the aorta reduces renal perfusion pressure, activating RAAS, plus a direct upstream pressure effect.
Monogenic disorders (e.g., Liddle syndrome, glucocorticoid-remediable aldosteronism)	Nearly all act through increased renal tubular sodium transport or excess mineralocorticoid activity/signaling, producing salt-sensitive, low-renin hypertension.

Clues that should raise suspicion for a secondary cause include: treatment-resistant hypertension, abrupt worsening of previously controlled BP, disproportionate target-organ damage for the BP level, unprovoked hypokalemia, and onset at a young age (Harrison's Principles of Internal Medicine, 22nd ed.).

The Core Distinction

Primary hypertension: diffuse, multifactorial dysregulation of BP-controlling systems (renal sodium handling, RAAS, SNS, vascular structure) with no single reversible lesion - it is managed, not cured.
Secondary hypertension: a single dominant, mechanistically distinct driver (a hormone-secreting tumor, a stenotic vessel, a structural defect, or a parenchymal disease) that is frequently correctable or curable once identified - this is why secondary causes are actively screened for, especially in young patients or those with resistant or abruptly worsening disease.